https://doi.org/10.1038/bmt.2017.161
F
Fiona L. Dignan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
3.8K
Citations
30
h-index
41
i10-index
Fiona L. Dignan is an academic researcher from Manchester University NHS Foundation Trust. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 30, co-authored 69 publications.
Papers by this author
worksDiagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation
2017 · Bone Marrow Transplantation · 334 citations
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
2021 · Leukemia · 113 citations
https://doi.org/10.1038/s41375-021-01466-0
Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group
2019 · Bone Marrow Transplantation · 106 citations
https://doi.org/10.1038/s41409-019-0705-z
<scp>BCSH</scp>/<scp>BSBMT</scp>/<scp>UK</scp> clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation
2016 · British Journal of Haematology · 48 citations
https://doi.org/10.1111/bjh.14027
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)
2025 · BMJ Open · 1 citations
https://doi.org/10.1136/bmjopen-2024-086223
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat